Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001765581-22-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01+ | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $142.85 | -12.5K | 329.0K | -4% | -$1.79M |
| D | 2022-03-03 | 2022-03-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $46.83 | +9,700 | 335.5K | +3% | +$454.3K |
| D | 2022-03-03 | 2022-03-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -9,700 | 48.4K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-01 | S | D | 3,041 | $136.73 | 329,187 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $136.18 to $137.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-03-01 | M | A | 9,700 | $46.83 | 335,488 | D | — | — | |
| 3 | Common | Ordinary Shares | 2022-03-02 | S | D | 6,000 | $150.00 | 322,987 | D | — | — | |
| 4 | Common | Ordinary Shares | 2022-03-01 | S | D | 3,260 | $135.73 | 332,228 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.18 to $136.12. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 5 | Common | Ordinary Shares | 2022-03-01 | S | D | 200 | $137.40 | 328,987 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.255 to $137.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-01 | M | D | 9,700 | $0.00 | 48,432 | D | $46.83 · — to 2022-08-08 | 9,700 Ordinary Shares | (F6) This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016. |